Medrobotics Corporation is a privately-held, surgical products company with a core competency in robotics. The Company’s vision is to provide more patients with access to minimally invasive surgery. Headquartered in Raynham, Massachusetts, Medrobotics manufactures and markets its flagship product, the Flex® Robotic System, a robot-assisted platform that provides surgeons with single-site access and visualization of hard-to-reach anatomical locations.
The Flex® Robotic System is based on a core flexible, steerable scope technology that surgeons can use to navigate around anatomy with an integrated 3D high-definition vision system. Once positioned, the scope can become rigid to provide a stable platform through which flexible instruments can be deployed to perform procedures in a way that is not possible with line-of-sight approaches.
Medrobotics received FDA clearance to market the Flex® Robotic System in the United States in July 2015. Medrobotics received the European CE mark for the Flex® Robotic System in 2014.